For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
Rescheduling marijuana to a less restrictive category will benefit liberty and public health
President Trump signed an executive order today intended to fast track the rescheduling of cannabis from a Schedule I substance, the same as heroin,…
News Release
CEI Study: Government laws against pharmacy ownership would increase costs, restrict access for consumers
Innovation is reshaping how Americans get their prescription medications. Whether picking up medications in person, ordering online, or getting same-day delivery from services like Capsule,…
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Search Posts
Comment
Are Risk Assessment And The Precautionary Principle Equivalent?
EDITOR’S NOTE: The following paper was prepared for the June 20-21, 2002 International Society of Regulatory Toxicology and Pharmacology workshop on the Precautionary Principle,…
Comment
The Precautionary Principle: Protectionism and Environmental Extremism by Other Means
The Precautionary Principle: Protectionism and Environmental Extremism by Other Means …
Op-Eds
Want to Avoid GM Foods? This Regulation Won’t Help
Yesterday, the European Parliament’s Environment Committee voted to expand the EU’s labelling requirement for Genetically Modified foods. The measure, in the form of…
Op-Eds
Worrying About Frankenstein’s Monster
A specter is haunting Europe—called the “precautionary principle”. As generally defined, the precautionary principle states that a product or technology can be banned even if…
Citation
Cancer Doctors on the FDA
Op-Eds
Battling Hunger With Biotechnology
Needless restrictions on agricultural biotechnology would harm the world's ability to battle hunger in the 21st century, say Gregory Conko and C.S. Prakash, co-founders…